ABT 202
Alternative Names: A-317491Latest Information Update: 23 Jan 2013
At a glance
- Originator Abbott Laboratories; NeuroSearch
- Developer Abbott Laboratories
- Class Analgesics
- Mechanism of Action Purinergic P2X3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Pain